Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Alofisel 5 × 106 cells/mL dispersion for injection.
Takeda
Perianal fistulising Crohn´s disease
1 trial -
Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar sus
Pfizer Australia Pty Ltd
VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)
Hipra Human Health S.L.
COVID-19
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted), Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection COVID 19 mRNA Vaccine, Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Comirnaty JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Nuvaxovid dispersion for injection COVI
The George Institute
COVID-19 infection
1 trial -
Benlysta 200 mg solution for injection in pre-filled pen.
GlaxoSmithKline
Systemic Lupus Erythematosus
1 trial -
Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe
LEO Pharma A/S
Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
1 trial -
Brucea javanica oil emulsion injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Bupivacaine Injection [Marcaine]
The University of Hong Kong
Acute Pain
1 trial -
Bupivacaine Liposome Injection
Jian Li
Local Analgesia Via Infiltration
1 trial -
Buprenorphine Extended-Release Injection
Indivior Pty Ltd
Opioid Use Disorder
1 trial -
CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent), Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
Disc Medicine
Asplenia
1 trial -
Cinobufacini injection
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
The George Institute
Covid-19 infection
1 trial -
Commercial Hylenex® recombinant (hyaluronidase human injection)
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Danhong injection
BRIGHT MINDS BIOSCIENCES INC.
Acute Stroke
1 trial -
Danhong injection
BRIGHT MINDS BIOSCIENCES INC.
Unstable Angina Pectoris
1 trial -
Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection
Disc Medicine
Solid tumors
1 trial -
Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial -
EXPAREL 1.3 % in 20 ML Injection
Pacira Ireland Limited
Rotator Cuff Tear
1 trial -
Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets
The George Institute
Left ventricular thrombosis., Acute mycocardial infarction (AMI)
1 trial -
Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Enbrel 25 mg powder and solvent for solution for injection, ADALIMUMAB, ETANERCEPT, Humira 20 mg solution for injection in pre-filled syringe
Fondazione Telethon ETS
Juvenile Idiopathic Arthritis
1 trial -
Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection
The George Institute
Coronary artery chronic total occlusion
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources